Harvest Group Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-111
Closed -$10K 484
2020
Q4
$10K Hold
111
0.01% 228
2020
Q3
$10K Hold
111
0.01% 224
2020
Q2
$9K Hold
111
0.01% 221
2020
Q1
$9K Hold
111
0.01% 216
2019
Q4
$10K Sell
111
-168
-60% -$15.1K 0.01% 245
2019
Q3
$24K Hold
279
0.03% 143
2019
Q2
$25K Sell
279
-32
-10% -$2.71K 0.03% 133
2019
Q1
$27K Buy
+311
New +$25K 0.02% 136

Other funds holding NVS

Harvest Group Wealth Management's NVS Position: Q1 2021 in Review

Harvest Group Wealth Management sold out of Novartis (NVS) in Q1 2021, closing a stake of 111 shares — an estimated $10K sold.

Harvest Group Wealth Management first reported a position in NVS in Q1 2019 and held it in 8 quarters. The position peaked at $27K in Q1 2019. 1,135 funds tracked by Wall St. Rank hold NVS as of Q1 2021.

  • Harvest Group Wealth Management reported no remaining Novartis position as of Q1 2021 after selling out during the quarter.
  • Harvest Group Wealth Management sold 111 Novartis shares in Q1 2021, an estimated $10K.
  • Harvest Group Wealth Management first reported a position in Novartis in Q1 2019 and held it in 8 quarters.
  • Harvest Group Wealth Management's Novartis position peaked at $27K in Q1 2019.
  • 1,135 funds tracked by Wall St. Rank held Novartis as of Q1 2021.

Based on Harvest Group Wealth Management's 13F filing for Q1 2021, filed 4 May 2021.